 DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 05, 2021 GLOBE NEWSWIRE -- Nabriva Therapeutics plc NASDAQ: NBRV, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive Officer at Nabriva, will provide a company overview and business update at the Jefferies London Healthcare Conference. The presentation will be available on-demand beginning on Thursday, November 18 at 8:00am GMT 3:00am ET through Friday, November 19 at 5:00pm GMT 12:00pm ET. Management will host investor meetings on Thursday and Friday, November 18-19, 2021. 